A Dose Escalation Study of Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2013
At a glance
- Drugs Vorinostat (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 07 Jun 2010 To date, 8 patients have been enrolled, according to a poster presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
- 16 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.